My DMs have been flooded all week. "Derek, is this the end?" "Are prices going up?" "Should I stock up?"
So I broke it all down:
→ What 66-80 actually does
→ How it hits compounding pharmacies (spoiler: it's real)
→ Why ALL research peptides might see price increases (not just GLP-1s)
→ The liquidation sales happening right now—and why I don't think 66-80 is the reason
→ What I'm actually watching over the next few months
Short version: I've yet to see anything kill this space. I don't see it happening as fast as everyone's panicking about. But there ARE real implications here.
Full breakdown 👇